Enjoy complimentary customisation on priority with our Enterprise License!
The breast cancer therapeutics market size is forecast to increase by USD 15.64 billion at a CAGR of 8.4% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of breast cancer, which is the most common cancer among women worldwide. According to the World Health Organization, there were approximately 2.3 million new cases of breast cancer in 2020. The market is also driven by the emergence of novel therapeutics, such as targeted therapies and immunotherapies, also advanced cancer diagonistic which offer more effective and personalized treatment options. However, the high cost of breast cancer treatment remains a major challenge for patients and healthcare systems, limiting access to these advanced therapies for many. Despite this, the market is expected to continue growing due to the increasing demand for effective treatments and the ongoing research and development efforts in the field.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Disease Type
7 Market Segmentation by Therapy
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.